Wolfram Doehner
forschungsdatenbank.charite.de
0000-0001-7598-708X
315 papers found
Refreshing results…
The obesity paradigm on outcome in heart failure with reduced ejection fraction.
Poststroke Cardiovascular Management: Current Concepts, Integrated Care, and Future Developments
Heart failure and the heart–brain axis
Enhanced diagnostic workup increases pathological findings in patients with acute ischaemic stroke: results of the prospective HEBRAS study
The polypill in cardiovascular prevention: successful through simplification?
The small molecule ACM‐001 improves cardiac function in a rat model of severe cancer cachexia
Comparison of Investigator-Reported and Centrally Adjudicated Heart Failure Outcomes in the EMPEROR-Reduced Trial
Plasma bioactive adrenomedullin predicts outcome after acute stroke in early rehabilitation
Magnetic resonance imaging of organ iron before and after correction of iron deficiency in patients with heart failure
The DZHK research platform: maximisation of scientific value by enabling access to health data and biological samples collected in cardiovascular clinical studies
Bone status in men with heart failure: results from the Studies Investigating Co‐morbidities Aggravating Heart Failure
Glucose-Induced Hemodynamic and Metabolic Response of Skeletal Muscle in Heart Failure Patients with Reduced vs. Preserved Ejection Fraction—A Pilot Study
Weight change and clinical outcomes in heart failure with reduced ejection fraction: insights from EMPEROR‐Reduced
Systematic review and meta‐analysis of intravenous iron‐carbohydrate complexes in HFrEF patients with iron deficiency
Efficacy and safety of vitamin-K antagonists and direct oral anticoagulants for stroke prevention in patients with heart failure and sinus rhythm: An updated systematic review and meta-analysis of randomized clinical trials
How to optimize the adherence to a guideline-directed medical therapy in the secondary prevention of cardiovascular diseases: a clinical consensus statement from the European Association of Preventive Cardiology
Sodium–glucose cotransporter 2 inhibitor treatment lowers serum uric acid in patients with heart failure with reduced ejection fraction – lessons from clinical trials. Letter regarding the article ‘Dapagliflozin reduces uric acid concentration, an independent predictor of adverse outcomes in DAPA‐HF’
Polypill Strategy in Secondary Cardiovascular Prevention
Cardiac Thrombogenicity in Stroke: Mechanisms and Evaluation
Uric acid and sodium-glucose cotransporter-2 inhibition with empagliflozin in heart failure with reduced ejection fraction: the EMPEROR-reduced trial
Missing publications? Search for publications with a matching author name.